Vacancy



Ayurdoctor.com vacancy segment is only a platform to read the available job opportunities posted by the employers . We strongly recommend all the candidates to verify the authenticity of the employer / job post . Please note that it is your choice to accept or deny the job post and apply to the particular employer more over take the decision to go ahead with it . We request you to send us an email to info@ayurdoctor.com with subject Fake job when ever you suspect on any job posting . Ayurdoctor team is not responsible for any fake posting and related consequences .

   
Name*
Mobile*
Email *
I Agree
  Submit
Close
Welcome To World's NO:1 Ayurveda Jobsite | India's Best Ayurveda Website

Effect of Anuvasana Basti with Ksheerabala Taila in Sandhigata Vata (Osteoarthritis)

by: ayurdoctor Published on24-12-14 05:34 PM
Osteoarthritis (OA) is the second most common rheumatologic problem in India and has a prevalence rate of 22-39%. It is characterized primarily by articular cartilage degeneration and a secondary periarticular bone response. World-wide prevalence rate of OA is 20% for men, 41% for women and it causes pain or dysfunction in 20% of the elderly respectively.  Relieving pain stiffness and improving physical functions are the important goals of the present day therapy. Although OA itself is not a life-threatening disease, Quality of life can significantly deteriorate with pain and loss of mobility causing dependence and disability. In Ayurveda, the disease Sandhigata Vata resembles with OA, which is described under Vatavyadhi.

Anuvasana Basti is the treatment of choice in Vatavyadhi. Ksheerabala Taila is one of the most popular oil preparations in Ayurveda and recognized as a very effective remedy for neurological disorders such as facial paralysis, sciatica, hemiplegia, paraplegia, poliomyelitis and other such conditions. The similar preparation has been mentioned by almost all ancient Ayurvedic texts but with different names. Charaka mentioned as Shatasahasra Paka Bala Taila.Sushruta mentioned as Shata Paka Bala Taila and Ashtanga Hridaya mentioned as Shata Paka-Sahasra Paka Bala Taila.The ingredients of this preparation are Ksheera (Cow's milk), Bala (Sida cordifolia Linn.) and Tila Taila (Sesame oil). Ksheerabala Taila is used for the purpose of Anuvasana Basti. S. cordifolia has been reported to possess analgesic, anti-inflammatory as well as hepato-protective activity.Charaka advises Anuvasana Basti to be administered in Vatavyadhis.The objective of the present study is to evaluate the effect of Ksheerabala-Taila Anuvasana Basti in Sandhigata Vata.


 Materials and Methods


A total of 30 subjects with OA knees were recruited for the study among which 25 subjects (16 female and 9 male) completed the whole course and 5 dropped out. The study was approved by the Institutional Review Board (IRB) and Institutional Ethics Committee (IEC) (Ref No.: SDMAMC/03-04/D-1059). Signed informed consent was obtained from all the participants.

Inclusion criteria

Persistent pain for 3 months prior to recruitment
Moderate-to-severe pain on walking
Fully ambulant, literate and willing to participate in the study.

Exclusion criteria

Acute knee pain
Secondary OA due to rheumatoid arthritis, gout, septic arthritis, tuberculosis, tumor, trauma, or hemophilia
Major medical or psychiatric disorders.


Design

It is a single group clinical study with pre-test and post-test design. A special proforma was prepared with all points of history taking, examination, laboratory and roentgen-logic investigations to confirm the diagnosis as mentioned in our classics and allied sciences.

Intervention

The patients were treated with Anuavasana Basti with Ksheerabala Taila 120 ml for 10 days. 5 g of Saindhava was added to Ksheerabala Taila while administering Basti. The Basti was given daily between 2 pm and 3 pm in the afternoon after food.

The subjects were not given any other medications or topical treatments during the trial. The patients were assessed pre-test, post-test and after the follow-up period of 20 days.

Basti Pratyagamana Laxanas were all noted and No adverse events were noted during the trial.

Criteria for assessment

Subjective parameters

I Visual Analog Scale (VAS) was used for assessing pain.

II Swelling

Grade 0 - No swelling

Grade 1 - Slight swelling

Grade 2 - Moderate swelling

Grade 3 - Severe swelling

III Tenderness was evaluated on the basis of standard criteria of "Ritchie Articular Index."

Grade 0 - Normal - Absent or no tender

Grade 1 - Mild - Tender

Grade 2 - Moderate - Tenderness and wincing

Grade 3 - Severe - Tenderness, wincing and withdrawal

IV Crepitus

Grade 0 - Normal - No crepitus

Grade 1 - Mild - Crepitus complained by patient but not felt on examination

Grade 2 - Moderate - Crepitus felt on examination

Grade 3 - Severe - Crepitus felt and heard on examination

V Walking velocity

Grade 0 - Normal - 20 min in 20 s

Grade 1 - Mild - 20 min in 30 s

Grade 2 - Moderate - 20 min in 40 s

Grade 3 - Severe - 20 min in 50 s

Objective parameters

Radiological findings

The Kellgren-Lawrence index was used to assess the changes in radiological finding.

Grade 1 - Doubtful narrowing of joint space and possible osteophytic lipping

Grade 2 - Definite osteophytes, definite narrowing of joint space

Grade 3 - Moderate multiple osteophytes, definite narrowing of joints space, some sclerosis and possible deformity of bone contour

Grade 4 - Large osteophytes, marked narrowing of joint space, severe sclerosis and definite deformity of bone contour

Overall effect of therapy

No improvement: 0-25%, mild improvement: >25-50%, moderate improvement: >50-75%, marked improvement: >75-<100% and complete remission: 100%.

   Observations

In present study, 48% of the patients gave a history of pain in both knee joints, while 40% complained of pain in right knee joint, only 12% in left knee joint. 84% of the patients were found were having Santarpanottha and 16% were Apatarpanottha Vyadhi. Majority of the patients (64%) had the history of complaints between 1 and 5 years, followed by more than 5 years (20%) and less than 1 year (16%). Maximum (52%) patients had Kellegren Roentgenologic evidence of OA in Grade 2, followed by Grade 3 (40%) and Grade 1 (8%). There were no patients in Grade 4.

Most of the patients had Basti Pratyagama Kala in 6-9 hrs (40%), followed by 3-6 hrs (32%), less than 3 hrs (16%) and more than 9 h (12%). The maximum Basti retension time noted was 9.53 h and minimum was 1.43 h. The mean Basti retention time was 4.56 h.

  Results

There was significant reduction (P < 0.05) in subjective symptoms such as pain, swelling, tenderness, crepitus and walking velocity. There was insignificant change in radiological findings . In the overall effect of the therapy, 56% (14) had mild improvement, 48% (08) had moderate improvement and 12% (03) had no improvement.

Discussion

Sandhigata Vata is a disorder dominated by pain affecting the Sandhi (joint). It is caused by morbid Vata Dosha. Kapha Dosha may also be involved in the clinical presentation. The vitiated Dosha or Doshas afflict the Mamsa, Asthi and Snayu. It is more evident in Asthi Dhatu with which Vayu has Ashraya-Ashrayee Bhava Sambhanda.

As per age-wise distribution, maximum numbers of patients (60%) in this study were in the age group of 51-60 years. This is the age wherein Hani (deterioration) of Dhatus starts. In this study, maximum numbers of patients (64%) were females. Sex hormones have long been considered a possible factor in the systemic predisposition to OA, especially in women. 

Nearly 16% of patients had chronicity below 1 year, whereas 64% of patients were between 1 and 5 years and remaining 20% of patients were more than 5 years.

Significant results (P < 0.05) were found in all the cardinal symptoms - Sandhiruja (pain), Shotha (swelling), tenderness and crepitus. There was significant improvement in walking velocity. This proves that Anuvasana Basti with Ksheerabala Taila is effective in Sandhigata Vata. Pain and crepitus are mainly due to Vata Dosha and above data proves that Anuvasana Basti with Ksheerabala Taila controls Vata Dosha and relieves these symptoms.

Probable mode of action of Basti

Basti Chikitsa is the prime treatment modality of Ayurveda. It is also considered as Ardha Chikitsa (half treatment). Sneha or Anuvasana Basti (unctuous enema) promotes Bala (strength) of the person who is emaciated and debilitated. About the possibility of the absorption of Basti Dravyas (drugs) from the colon, some are of the opinion that substances other than water, salt, etc., are not absorbed from the large gut; but this is physiological phenomenon occurring in day-to-day life, while the colon mucosa under the effect of the medication can be rendered to absorb the unusual substance also from the large gut. Favoring this view modern medical science is suggestive of some of the nutrient enemas meant for the nutrition of the body, where absorption of carbohydrate, fat and protein is mentioned. 

Observation of modern medical science that administration of sodium chloride improves fat absorption  is curiously coinciding with the usage of salt designed by Ayurvedic medical authorities in Sadyo-Snehana and in many Basti Dravya preparations along with the different Sneha Dravyas. Charaka narrates the role played by Lavana along with the Sneha by the words "Lavanopitaha Snehana Snehayantyachiratnaram.0" Charaka while assessing the Anuvasana Basti records the digestion of Sneha by the words "Sneham Pachati Pavakah" and after digestion Dravyas can be absorbed to cause the affect on the body.


 Conclusion  


Anuvasana Basti with Ksheerabala Taila was significant in reducing the subjective symptoms of Sandhigata Vata. There was no significant improvement in radiological findings.


















































































Sourse :http://www.ayujournal.org/
Online Doctors
Dr DR Satish Kumar
Panchakarma / Detoxification
Dr Dr Nirav Joshi
Panchakarma / Detoxification
If your Company or Treatment Centre seeks Ayurvedic Professionals (Doctors, Therapist, Manager etc) you can announce your needs to our website.
Advertisement
Advertisement
Advertisement

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player